ESC 365 - Long term outcomes of first and second generation drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from SORT OUT III, IV and V trials.

ESC Premium Access

Long term outcomes of first and second generation drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from SORT OUT III, IV and V trials.

Session: Long-term outcome of coronary stents and scaffolds

Topic: PCI: long-term outcome

Speaker: Professor M. Maeng (Aarhus, DK)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Michael Maeng

Aarhus University Hospital, Aarhus (Denmark)

2 presentations

0 follower

4 more presentations in this session

State of the Art: does DES type impact long-term outcome and, potentially, DAPT duration?

Speaker: Professor S. Massberg (Munich, DE)

Four-year clinical outcome following randomised use of zotarolimus-eluting stents versus everolimus-eluting stents in all-comers: insights from the DUTCH PEERS trial

Speaker: Professor C. von Birgelen (Enschede, NL)

Sex-related differences in patients undergoing complex coronary interventions in the era of 2nd generation DES.

Speaker: Doctor B. Vogel (New York, US)

State of Affairs: a cautiously optimistic perspective on bioresordable scaffolds

Speaker: Doctor G. Stone (New York, US)

Access the full session

Long-term outcome of coronary stents and scaffolds

Speakers: Professor M. Maeng, Professor S. Massberg, Professor C. von Birgelen, Doctor B. Vogel, Doctor G. Stone

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources